Seastar Medical Reports Third Quarter 2024 Financial Results And Provides A Business Update
In November 2024 we received FDA Breakthrough Device Designation for the SCD for use in chronic dialysis, our first such designation for a chronic indication. This is our fourth FDA award of ...